Your browser doesn't support javascript.
loading
Letermovir prophylaxis lowers the incidence of Non-CMV infections after allogeneic hematopoietic cell transplantation.
Bashey, Saffiya Z; Solomon, Scott R; Zhang, Xu; Morris, Lawrence E; Kent Holland, H; Bachier, Lizamarie; Solh, Melhem M.
Affiliation
  • Bashey SZ; The Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Solomon SR; Blood and Marrow Transplant Program at Northside Hospital, Atlanta Georgia, GA, USA.
  • Zhang X; Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Morris LE; Blood and Marrow Transplant Program at Northside Hospital, Atlanta Georgia, GA, USA.
  • Kent Holland H; Blood and Marrow Transplant Program at Northside Hospital, Atlanta Georgia, GA, USA.
  • Bachier L; Blood and Marrow Transplant Program at Northside Hospital, Atlanta Georgia, GA, USA.
  • Solh MM; Blood and Marrow Transplant Program at Northside Hospital, Atlanta Georgia, GA, USA. msolh@bmtga.com.
Bone Marrow Transplant ; 59(4): 564-565, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38263393

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinazolines / Cytomegalovirus Infections / Hematopoietic Stem Cell Transplantation / Acetates Type of study: Incidence_studies / Risk_factors_studies Limits: Humans Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2024 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinazolines / Cytomegalovirus Infections / Hematopoietic Stem Cell Transplantation / Acetates Type of study: Incidence_studies / Risk_factors_studies Limits: Humans Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2024 Document type: Article Affiliation country: United States